This design choice introduces potential bias, particularly for subjective outcomes, but it reflects the practical reality that these treatments have different injection devices and titration schedules that would make blinding extremely difficult
If patients experience persistent difficulty with injections, inconsistent medication effects, or injection site reactions, they should contact their healthcare provider for additional guidance
How Tirzepatide Targets Both GIP And GLP-1 Pathways Tirzepatide, sold under the brand name Mounjaro for diabetes and Zepbound for weight loss, is a newer medication with a unique dual action
Report side effects, no matter how minor they may seem
Clinical trial data shows GERD symptoms occur in approximately 1.71.8% of patients taking Wegovy, while dyspepsia (including heartburn) affects 2.33.2% of patients